Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.
Department of Therapeutics and Clinical Pharmacy, Faculty of Pharmacy, Applied Science Private University, Amman, Jordan.
Int J Clin Pract. 2021 May;75(5):e13986. doi: 10.1111/ijcp.13986. Epub 2021 Jan 12.
The purpose of this study was to assess pharmacists' knowledge and attitude towards early detection of colorectal cancer (CRC) in Jordan and to explore potential predictor variables of such knowledge and attitude.
An electronic, self-reported questionnaire was used to collect data about demographics, knowledge and attitude regarding early detection of CRC. Both content and face validity were tested in a panel of experts. The participants' responses were analysed using descriptive statistics and multiple linear regressions.
The 352 pharmacists (78% females, 94% Jordanian) had a median age of 28 years and graduated mostly (83%) from public universities. Surprisingly, 90% were not able to identify carcinoembryonic antigen (CEA) as a non-accurate diagnostic method and almost one-third did not identify the correct screening tests. On a scale of 5, the majority of participants (59%) had moderate knowledge scores (3 or 4) in case scenarios. The median knowledge Percent of Maximum Possible (POMP) score was 67% and higher scores were associated with more years since graduation, pharmacists with MSc degree and higher, working in urban areas, studying oncology course and received oncology training (P < .05). Most participants showed a positive attitude towards early detection of CRC (median attitude POMP score was 78%). However, none of the analysed variables predicted their level of attitude.
Although the majority of pharmacists demonstrated a positive attitude towards early detection of CRC, their knowledge was inadequate. The study highlighted the importance of optimising the education programmes to improve the pharmacists' knowledge about CRC early detection and preparing the pharmacists for participating in future national screening initiatives.
本研究旨在评估约旦药剂师对结直肠癌（CRC）早期检测的知识和态度，并探讨其知识和态度的潜在预测变量。
采用电子、自我报告问卷收集有关人口统计学、CRC 早期检测知识和态度的数据。内容和表面效度在一组专家中进行了测试。使用描述性统计和多元线性回归分析参与者的反应。
352 名药剂师（78%为女性，94%为约旦人）的中位年龄为 28 岁，主要（83%）毕业于公立大学。令人惊讶的是，90%的药剂师无法将癌胚抗原（CEA）识别为非准确的诊断方法，近三分之一的药剂师无法识别正确的筛查测试。在 5 分制的情况下，大多数参与者（59%）在案例情景中具有中等程度的知识得分（3 或 4 分）。中位数知识最大可能得分（POMP）为 67%，较高的分数与毕业后的年限、具有硕士学位和更高学位的药剂师、在城市地区工作、学习肿瘤学课程和接受肿瘤学培训有关（P<.05）。大多数参与者对 CRC 的早期检测表现出积极的态度（中位数态度 POMP 得分为 78%）。然而，没有一个分析变量预测了他们的态度水平。
尽管大多数药剂师对 CRC 的早期检测表现出积极的态度，但他们的知识不足。该研究强调了优化教育计划的重要性，以提高药剂师对 CRC 早期检测的知识，并为药剂师参与未来的国家筛查计划做好准备。
